Physician profile
Gary Gordon
NPI 1245291780
$23,221.52
in general payments reported to CMS, 2019-2025
84 companies · $2,940 in 2025
The $2,940 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,878 · 2020: $2,256 · 2021: $1,562 · 2022: $2,051 · 2023: $2,759 · 2024: $9,776 · 2025: $2,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,013 · Food and Beverage: $6,579 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Long Term Medical Supply Or Device Loan: $299 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,012.50 |
| Food and Beverage | $6,578.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Long Term Medical Supply Or Device Loan | $299.10 |
| Education | $128.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $7,012.50 | 2024 | Trinav Infusion System |
| Seagen INC. | $1,919.81 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Genentech USA, INC. | $1,395.60 | 2019-2025 | Phesgo, Kadcyla, Perjeta |
| Merck Sharp & Dohme LLC | $1,326.02 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $1,279.53 | 2019-2025 | Piqray, Kisqali |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Janssen Biotech, INC. | $564.42 | 2019-2025 | Tecvayli, Erleada, Darzalex |
| Astrazeneca Pharmaceuticals LP | $539.21 | 2019-2025 | Lynparza, Tagrisso, Imfinzi |
| Pfizer INC. | $424.48 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $371.17 | 2019-2023 | Imbruvica, Epkinly |
| Incyte Corporation | $353.65 | 2019-2025 | Jakafi, Monjuvi |
| Lilly USA, LLC | $331.38 | 2019-2024 | Verzenio, Jaypirca |
| Amgen INC. | $301.25 | 2019-2023 | Lumakras |
| Gilead Sciences, INC. | $262.27 | 2021-2025 | Trodelvy |
| E.R. Squibb & Sons, L.L.C. | $248.48 | 2019-2025 | Opdivo, Eliquis |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $244.86 | 2021-2025 | |
| Abbvie INC. | $241.24 | 2019-2025 | |
| Genzyme Corporation | $238.60 | 2020-2025 | |
| Astellas Pharma US INC | $228.68 | 2019-2025 | Padcev, Vyloy, Xtandi |
| Daiichi Sankyo INC. | $225.67 | 2019-2025 | Enhertu, Vanflyta |
| Janssen Pharmaceuticals, INC | $224.01 | 2019-2024 | Xarelto |
| Novocure INC. | $195.80 | 2019-2025 | Optune Lua (Novottf-200t) |
| Emd Serono, INC. | $190.18 | 2019-2025 | Bavencio, Tepmetko |
| Servier Pharmaceuticals LLC | $148.75 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.20 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $146.80 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $145.26 | 2021-2023 | Libtayo |
| Coherus Oncology, INC. | $144.53 | 2020-2025 | Loqtorzi |
| G1 Therapeutics, INC. | $128.51 | 2022-2023 | Cosela |
| Takeda Pharmaceuticals U.S.A., INC. | $111.53 | 2019-2025 | Fruzaqla |
| Blueprint Medicines Corporation | $107.51 | 2020-2025 | Ayvakit |
| Glaxosmithkline, LLC. | $103.85 | 2022-2024 | Jemperli, Zejula, Benlysta |
| Beigene USA, INC. | $101.48 | 2021-2025 | Brukinsa, Tevimbra |
| Beone Medicines USA, INC. | $90.94 | 2025 | Tevimbra, Brukinsa |
| Exelixis INC. | $85.83 | 2020-2022 | |
| Deciphera Pharmaceuticals INC. | $83.08 | 2022-2024 | Qinlock |
| Alexion Pharmaceuticals, INC. | $82.10 | 2019-2024 | Ultomiris |
| Pharmacosmos Therapeutics INC. | $73.61 | 2022-2024 | Cosela |
| Puma Biotechnology, INC. | $73.26 | 2020-2024 | |
| Karyopharm Therapeutics INC. | $70.36 | 2021-2022 | |
| Tersera Therapeutics LLC | $66.38 | 2023-2025 | Xermelo, Zoladex |
| Celgene Corporation | $65.93 | 2019-2025 | Reblozyl, Opdualag |
| Tesaro, INC. | $60.79 | 2019 | |
| Inari Medical, INC. | $54.50 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Genentech, INC. | $49.95 | 2021 | |
| Mirati Therapeutics, INC. | $49.58 | 2023-2024 | Krazati |
| Tempus Ai, INC | $49.25 | 2024-2025 | Xt Cdx |
| Aveo Pharmaceuticals, INC. | $49.24 | 2022-2024 | Fotivda |
| Morphosys, US INC. | $48.18 | 2021-2023 | Monjuvi |
| Agios Pharmaceuticals, INC. | $46.86 | 2024 | Pyrukynd |
| Foundation Medicine, INC. | $38.84 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $38.25 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $37.87 | 2023-2025 | Empaveli |
| Dendreon Pharmaceuticals LLC | $34.50 | 2024 | Provenge |
| Rigel Pharmaceuticals, INC. | $34.44 | 2024 | Rezlidhia, Tavalisse |
| Springworks Therapeutics, INC. | $33.12 | 2025 | Ogsiveo |
| Pharmaessentia USA Corporation | $32.81 | 2025 | Besremi |
| Syndax Pharmaceuticals, INC. | $32.44 | 2025 | |
| Immunocore Limited | $30.32 | 2025 | Kimmtrak |
| Adaptive Biotechnologies Corporation | $28.06 | 2025 | Clonoseq |
| Sobi, INC | $27.91 | 2023 | |
| Stemline Therapeutics INC. | $25.84 | 2024 | Orserdu |
| Array Biopharma INC | $25.67 | 2025 | Lorbrena |
| Helsinn Therapeutics (U.S.), INC. | $25.35 | 2019-2023 | Akynzeo |
| Accord Healthcare, INC. | $24.98 | 2025 | |
| Cti Biopharma Corp. | $24.38 | 2022 | |
| Immunogen, INC. | $24.35 | 2024 | Elahere |
| Lexicon Pharmaceuticals, INC. | $22.95 | 2020 | |
| Fennec Pharmaceuticals, INC. | $22.74 | 2024 | Pedmark |
| Iovance Biotherapeutics, INC. | $20.05 | 2024 | Amtagvi |
| Epizyme, INC. | $19.43 | 2024 | Onivyde |
| Clovis Oncology, INC. | $19.35 | 2019 | |
| Macrogenics, INC. | $17.66 | 2022 | |
| Genmab U.S., INC. | $17.28 | 2024 | Epkinly |
| Tolmar, INC. | $17.16 | 2025 | Eligard, Rubraca |
| Pharmaand Gmbh | $17.16 | 2025 | Rubraca |
| Sun Pharmaceutical Industries INC. | $17.05 | 2024 | |
| Amneal Pharmaceuticals LLC | $16.95 | 2023 | Avastin |
| Ipsen Biopharmaceuticals, INC | $16.77 | 2022 | |
| Sirtex Medical INC | $14.93 | 2022 | |
| Dova Pharmaceuticals | $14.91 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.98 | 2021 | |
| Verastem, INC. | $12.13 | 2019 | |
| Acrotech Biopharma INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.